Featured posts

Trump said this drug could treat autism, but the FDA just approved it for a much rarer condition​Trump said this drug could treat autism, but the FDA just approved it for a much rarer condition 

Trump said this drug could treat autism, but the FDA just approved it for a much rarer condition​Trump said this drug could treat autism, but the FDA just approved it for a much rarer condition 

 The FDA announced a new approved use for the drug leucovorin, which Trump has touted as a treatment for autism. But the approval is for cerebral folate deficiency.  ​​The FDA announced a new approved use for the drug leucovorin, which Trump has touted as a treatment for autism. But the approval is for cerebral folate deficiency. 

Know More
Oysters and clams in 9 states could be contaminated with norovirus, FDA warns​Oysters and clams in 9 states could be contaminated with norovirus, FDA warns 

Oysters and clams in 9 states could be contaminated with norovirus, FDA warns​Oysters and clams in 9 states could be contaminated with norovirus, FDA warns 

 The FDA on Monday warned consumers about oysters and clams which could be contaminated with norovirus and were sent to nine states, including California, Florida and New York  ​​The FDA on Monday warned consumers about oysters and clams which could be contaminated with norovirus and were sent to nine states, including California, Florida and New York 

Know More
FDA vaccine chief to leave the agency next month after tumultuous tenure​FDA vaccine chief to leave the agency next month after tumultuous tenure 

FDA vaccine chief to leave the agency next month after tumultuous tenure​FDA vaccine chief to leave the agency next month after tumultuous tenure 

 The Food and Drug Administration’s vaccine chief, Dr. Vinay Prasad, will depart the agency next month, an FDA spokesperson said.  ​​The Food and Drug Administration’s vaccine chief, Dr. Vinay Prasad, will depart the agency next month, an FDA spokesperson said. 

Know More
RFK Jr. vowed to restore public trust in health. It’s not working, a new survey suggests.​RFK Jr. vowed to restore public trust in health. It’s not working, a new survey suggests. 

RFK Jr. vowed to restore public trust in health. It’s not working, a new survey suggests.​RFK Jr. vowed to restore public trust in health. It’s not working, a new survey suggests. 

 Americans are losing confidence in the nation’s public health agencies, a new survey finds. RFK Jr. has vowed to restore trust, but only 38% of adults trust him.  ​​Americans are losing confidence in the nation’s public health agencies, a new survey finds. RFK Jr. has vowed to restore trust, but only 38% of adults trust him. 

Know More
Tylenol orders for some pregnant women fell after Trump warned them not to take it​Tylenol orders for some pregnant women fell after Trump warned them not to take it 

Tylenol orders for some pregnant women fell after Trump warned them not to take it​Tylenol orders for some pregnant women fell after Trump warned them not to take it 

 After President Trump told pregnant women not to take Tylenol, orders for it declined among pregnant women who visited emergency rooms, according to new research.  ​​After President Trump told pregnant women not to take Tylenol, orders for it declined among pregnant women who visited emergency rooms, according to new research. 

Know More
GLP-1s could help curb substance use disorders, from alcohol to opioids, study suggests​GLP-1s could help curb substance use disorders, from alcohol to opioids, study suggests 

GLP-1s could help curb substance use disorders, from alcohol to opioids, study suggests​GLP-1s could help curb substance use disorders, from alcohol to opioids, study suggests 

 Evidence continues to mount suggesting that GLP-1 drugs like Ozempic and Wegovy may help people cut back on cigarettes, drinking and opioid use disorders and addiction.  ​​Evidence continues to mount suggesting that GLP-1 drugs like Ozempic and Wegovy may help people cut back on cigarettes, drinking and opioid use disorders and addiction. 

Know More
ChatGPT Health ‘under-triaged’ half of medical emergencies in a new study​ChatGPT Health ‘under-triaged’ half of medical emergencies in a new study 

ChatGPT Health ‘under-triaged’ half of medical emergencies in a new study​ChatGPT Health ‘under-triaged’ half of medical emergencies in a new study 

 ChatGPT Health — OpenAI’s new health-focused chatbot — frequently underestimated the severity of medical emergencies, according to a study published last week in the journal Nature Medicine  ​​ChatGPT Health — OpenAI’s new health-focused chatbot — frequently underestimated the severity of medical emergencies, according to a study published last week in the journal Nature Medicine 

Know More